JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Letter to the Editor
A comment on ‘The relationship between hepatocellular carcinoma and resolvin D1’ by Erdin et al.
We read the article entitled “The Relationship between Hepatocellular Carcinoma and Resolvin D1” by Erdin et al. with great interest. First of all, we congratulate the authors and editorial board for this informative and interesting article. Overall, this study by Erdin et al. demonstrated that Resolvin D1 may be a useful biomarker for predicting the HCC as an alternative to AFP. Further studies are warranted on this topic.


1. Erdin Z, G&uuml;l &Ouml;, Erg&uuml;l B, et al. The relationship between hepatocellular carcinoma and resolvin D1. <em>J Curr Hematol Oncol Res</em>. 2023;1(4):96-101.
2. Yang M, Song XQ, Han M, et al. The role of resolvin D1 in liver diseases. <em>Prostaglandins Other Lipid Mediat</em>. 2022;160:106634.
3. Li J, Deng X, Wang S, et al. Resolvin D1 attenuates CCl4 induced liver fibrosis by inhibiting autophagy-mediated HSC activation via AKT/mTOR pathway. <em>Front Pharmacol</em>. 2021;12:792414.
Volume 2, Issue 4, 2024
Page : 100
_Footer